CSIMarket
 


Oramed Pharmaceuticals Inc   (ORMP)
Other Ticker:  
 
 

ORMP's Income from Cont. Operations Growth by Quarter and Year

Oramed Pharmaceuticals Inc 's Income from Cont. Operations results by quarter and year




ORMP Income from Cont. Operations (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter August - 2.28 2.93 7.97
III Quarter May 2.28 4.07 4.35 1.97
II Quarter February 3.69 3.70 2.92 3.18
I Quarter November 2.54 4.30 2.53 -2.64
FY   8.51 14.35 12.73 10.48



ORMP Income from Cont. Operations third quarter 2020 Y/Y Growth Comment
Oramed Pharmaceuticals Inc reported fall in Income from Cont. Operations in the third quarter by -43.88% to $ 2.28 millions, from the same quarter in 2019.
The drop in the third quarter Oramed Pharmaceuticals Inc 's Income from Cont. Operations compares unfavorably to the Company's average Income from Cont. Operations rise of 29.87%.

According to the results reported in the third quarter, Oramed Pharmaceuticals Inc achieved the best Income from Cont. Operations growth in Major Pharmaceutical Preparations industry. While Oramed Pharmaceuticals Inc ' s Income from Cont. Operations drop of -43.88% ranks overall at the positon no. 27 in the third quarter.




ORMP Income from Cont. Operations ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter August - -22.18 % -63.24 % 67.44 %
III Quarter May -43.88 % -6.44 % 120.81 % -1.5 %
II Quarter February -0.27 % 26.71 % -8.18 % 74.73 %
I Quarter November -40.93 % 69.96 % - -
FY   - 12.73 % 21.47 % -4.47 %

Financial Statements
Oramed Pharmaceuticals Inc 's third quarter 2020 Income from Cont. Operations $ 2.28 millions ORMP's Income Statement
Oramed Pharmaceuticals Inc 's third quarter 2019 Income from Cont. Operations $ 4.07 millions Quarterly ORMP's Income Statement
New: More ORMP's historic Income from Cont. Operations Growth >>


ORMP Income from Cont. Operations (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter August - -43.98 % -32.64 % 304.57 %
III Quarter May -38.1 % 10 % 48.97 % -38.05 %
II Quarter February 45.28 % -13.95 % 15.42 % -
I Quarter November 11.4 % 46.76 % -68.26 % -
FY (Year on Year)   - 12.73 % 21.47 % -4.47 %




Income from Cont. Operations third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #1
Healthcare Sector #2
Overall #27

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
128.27 % 29.87 % -63.28 %
(May 31 2013)   (Aug 31 2018)
Income from Cont. Operations third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #1
Healthcare Sector #2
Overall #27
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
128.27 % 29.87 % -63.28 %
(May 31 2013)   (Aug 31 2018)

Income from Cont. Operations by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Oramed Pharmaceuticals Inc 's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
305.5 % 12.07 % -100 %
(Aug 31 2017)  


ORMP's III. Quarter Q/Q Income from Cont. Operations Comment
In the III. Quarter 2020 Oramed Pharmaceuticals Inc realized fall in Income from Cont. Operations sequentially by -38.1% to $ 2.28 millions, from $ 3.69 millions achived in the previous qaurter.

Albeit cyclical factors normally fuel III. Quarter 2020 results, this simply has not been sufficient to salvage Oramed Pharmaceuticals Inc 's outcome, Jason Thomas, market observer wrote and wrote that average quarter on quarter Income from Cont. Operations growth is at 12.07% for Oramed Pharmaceuticals Inc .

Within Major Pharmaceutical Preparations industry Oramed Pharmaceuticals Inc achieved highest sequential Income from Cont. Operations growth. While Oramed Pharmaceuticals Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is 25.


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #1
Healthcare Sector #2
Overall #25
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #1
Healthcare Sector #2
Overall #25
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
305.5 % 12.07 % -100 %
(Aug 31 2017)  


ORMP's III. Quarter Q/Q Income from Cont. Operations Comment
In the III. Quarter 2020 Oramed Pharmaceuticals Inc disclosed fall in Income from Cont. Operations sequentially by -38.1% to $ 2.28 millions, from $ 3.69 millions released in the previous reporting period.

Although periodic circumstance commonly fuel III. Quarter 2020 performance, that plainly could not be substantial to recover ORMP's III. Quarter 2020 performance, Jason Thomas, market observer wrote and mentioned that average quarter on quarter Income from Cont. Operations growth is at 12.07% for ORMP.

Within Major Pharmaceutical Preparations industry Oramed Pharmaceuticals Inc achieved highest sequential Income from Cont. Operations growth. While Oramed Pharmaceuticals Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is 25.


Oramed Pharmaceuticals Inc 's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(May 31 2020)
12 Months Ending
(Feb 29 2020)
12 Months Ending
(Nov 30 2019)
12 Months Ending
(Aug 31 2019)
12 Months Ending
(May 31 2019)
Cumulative Income from Cont. Operations 12 Months Ending $ 10.80 $ 12.58 $ 12.60 $ 14.36 $ 15.00
Y / Y Income from Cont. Operations Growth (TTM) -28.04 % -17.67 % -13.12 % 12.79 % -15.58 %
Year on Year Income from Cont. Operations Growth Overall Ranking # 36 # 1289 # 1686 # 1033 # 1632
Seqeuential Income from Cont. Operations Change (TTM) -14.21 % -0.1 % -12.25 % -4.31 % -1.85 %
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # 35 # 852 # 1987 # 1748 # 1611




Cumulative Income from Cont. Operations growth Comment
Oramed Pharmaceuticals Inc 's cumulative 12 months Income from Cont. Operations continue to drop, but on the faster rate at -28.04% year on year, at May 31 2020 compare to the -17.67% decrease at Feb 29 2020. If the Oramed Pharmaceuticals Inc 's fiscal year would end at May 31 2020, annual Income from Cont. Operations would be $11 millions.

Looking into Healthcare sector trailing twelve month Income from Cont. Operations increase, only one company had higher growth. While Total ranking has impoved so far to 36, from total ranking in previous quarter at 1289.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
49.3 %
1.94 %
-28.38 %
(Nov 30 2017)  

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 1
Healthcare Sector # 2
Overall # 36

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
163.51 %
33.66 %
-28.04 %
(Nov 30 2017)  


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 2
S&P 500 # 35
Cumulative Income from Cont. Operations growth Comment
Oramed Pharmaceuticals Inc 's cumulative 12 months Income from Cont. Operations continue to drop, but on the faster rate at -28.04% year on year, at May 31 2020 compare to the -17.67% decrease at Feb 29 2020. If the Oramed Pharmaceuticals Inc 's fiscal year would end at May 31 2020, annual Income from Cont. Operations would be $11 millions.

Looking into Healthcare sector trailing twelve month Income from Cont. Operations increase, only one company had higher growth. While Total ranking has impoved so far to 36, from total ranking in previous quarter at 1289.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
49.3 %
1.94 %
-28.38 %
(Nov 30 2017)  


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 1
Healthcare Sector # 2
Overall # 36

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
163.51 %
33.66 %
-28.04 %
(Nov 30 2017)  


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 2
S&P 500 # 35




Other Income from Cont. Operations Growth
Major Pharmaceutical Preparations Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
ORMP's Income from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for ORMP's Competitors
Income from Cont. Operations Growth for Oramed Pharmaceuticals Inc 's Suppliers
Income from Cont. Operations Growth for ORMP's Customers

You may also want to know
ORMP's Annual Growth Rates ORMP's Profitability Ratios ORMP's Asset Turnover Ratio ORMP's Dividend Growth
ORMP's Roe ORMP's Valuation Ratios ORMP's Financial Strength Ratios ORMP's Dividend Payout Ratio
ORMP's Roa ORMP's Inventory Turnover Ratio ORMP's Growth Rates ORMP's Dividend Comparisons



Companies with similar Income from Cont. Operations drop for the quarter ending May 31 2020 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending May 31 2020
Oramed Pharmaceuticals Inc -43.91 %$ -43.910 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HURC's Profile

Stock Price

HURC's Financials

Business Description

Fundamentals

Charts & Quotes

HURC's News

Suppliers

HURC's Competitors

Customers & Markets

Economic Indicators

HURC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071